Part of Cancer staging guidance sheets
Vulva (ICD10 C51)
Page contents
Stage groupings
FIGO 2021 staging summary
|
FIGO Stage |
Description |
|---|---|
|
I |
Tumour confined to the vulva |
|
IA |
Lesions ≤ 2 cm in size, confined to the vulva or perineum and with stromal invasion ≤ 1.0 mma, no nodal metastasis |
|
IB |
Lesions > 2 cm in size or with stromal invasion > 1.0 mma, confined to the vulva or perineum, with negative nodes |
|
II |
Tumour of any size with extension to adjacent perineal structures (lower third of urethra, lower third of vagina, anus) with negative nodes |
|
III |
Tumour of any size with or without extension to adjacent perineal structures (lower third of urethra, lower third of vagina, anus) with positive inguinofemoral nodes |
|
IIIA |
Tumour of any size with extension to upper part of adjacent perineal structures, or with any number of nonfixed, nonulcerated lymph node. Tumour of any size with disease extension to upper two-thirds of the urethra, upper two-thirds of the vagina, bladder mucosa, rectal mucosa, or regional lymph node metastases ≤5 mm |
|
IIIB |
Regional lymph node b metastases >5 mm |
|
IIIC |
Regional lymph node metastases with extracapsular spread |
|
IV |
Tumour invades other regional (upper 2/3 urethra, upper 2/3 vagina), or distant structures |
|
IVA |
Disease fixed to pelvic bone, or fixed or ulcerated regional lymph node metastases |
Note:
a Method for measurement of depth of invasion has been changed:
FIGO 2021 – The depth of invasion is measured from the basement membrane of the deepest, adjacent, dysplastic, tumour-free rete ridge (or nearest dysplastic rete peg) to the deepest point of invasion.
b Regional refers to inguinal and femoral lymph nodes
Isolated tumour cells do not change the stage but their presence should be recorded.
Download
Click on the box below to download a PDF version of this data sheet:
Last edited: 21 December 2022 5:16 pm
- Cancer staging guidance sheets
- Oral Cavity and mucosal lip (ICD10 C00.3-5, C02-C06)
- Malignant melanoma of upper aerodigestive tract (ICD10 C00-06, C09-14, C30-32)
- Pharynx (ICD10 C01, C02.4, C05.1-2, C09, C10.0, C10.2-3, C10.9, C11-13)
- Salivary glands (ICD10 C00-C14, C15.0, C30-C33, C41.1)
- Oesophagus including oesophagogastric junction (ICD10 C15, C16.0)
- Gastrointestinal stromal tumours (ICD10 C15-C20, C48.1-2)
- Stomach (ICD10 C16 - excluding C16.0)
- Small intestine (ICD10 C17)
- Appendix (ICD10 C18.1)
- Colon and rectum (ICD10 C18-C20)
- Anal and perianal skin (ICD10 C21)
- Liver (ICD10 C22.0)
- Intrahepatic bile ducts (ICD10 C22.1)
- Gallbladder (ICD10 C23)
- Distal extrahepatic bile duct (ICD10 C24.0)
- Perihilar bile ducts (ICD10 C24.0)
- Ampulla of vater (ICD10 C24.1)
- Pancreas (ICD10 C25)
- Nasal cavity and paranasal sinuses (ICD10 C30.0, C31.0, C31.1)
- Larynx (ICD10 C32.0, C32.1, C32.2, C10.1)
- Lung (ICD10 C34)
- Thymus tumours (ICD10 C37.9)
- Soft tissues (ICD10 C15-C26, C34-C37 C38.1-3, C47-C49, C51-C53, C58, C60-C68)
- Bone (ICD10 C40, C41)
- Melanoma of skin (ICD10 C00.0-2, C00.6, C21.2, C43, C51, C60, C63.2)
- Merkel cell carcinoma of skin (ICD10 C00, C44, C51, C60, 63.2, C80)
- Skin carcinoma of the head and neck (ICD10 C00.0-2, C00.6, C44.0, C44.2-4)
- Carcinoma of skin of the eyelid (ICD10 C44.1)
- Carcinoma of skin (excluding eyelid, head and neck, perianal, vulva and penis) (ICD10 C44.5-7, C63.2)
- Pleural mesothelioma (ICD10 C38.4)
- Breast tumours (ICD10 C50)
- Vulva (ICD10 C51)
- Cervix uteri (ICD10 C53)
- Uterine sarcomas
- Uterus - endometrium (ICD10 C54.1, C55)
- Ovarian, fallopian tube and primary peritoneal carcinoma (ICD10 C56, C57, C48.1, C48.2)
- Gestational trophoblastic neoplasms (ICD10 C58)
- Penis tumours (ICD10 C60)
- Prostate tumours (ICD10 C61.9)
- Testis tumours (ICD10 C62)
- Kidney tumours (ICD10 C64)
- Renal pelvis and ureter tumours (ICD10 C65 & C66)
- Urinary bladder tumours (ICD10 C67)
- Urethra tumours (ICD10 C68.0, C61.9)
- Carcinoma of conjuctiva (ICD10 C69.0)
- Melanoma of conjuctiva (ICD10 C69.0)
- Retinoblastoma (ICD10 C69.2)
- Melanoma of uvea (ICD10 C69.3-4)
- Carcinoma of lacrimal gland (ICD10 C69.5)
- Sarcoma of orbit (ICD10 C69.6)
- Thyroid gland (ICD10 C73.9)
- Adrenal cortex (ICD10 C74.0)
- Adrenal medulla and extra-adrenal paraganglia (ICD10 C74.1 C75.5)
- Parathyroid gland (ICD10 C75.0)
- Unknown primary - cervical nodes (ICD10 C77.0)
- Mycosis fungoides or sezary syndrome (ICD10 C84.0 and C84.1)
- T and B cutaneous lymphoma (ICD10, C82.6, C84.8, C86.6 and other C83-C86 if primary skin excluding C84.0 C84.1)
- Rhabdomyosarcoma (CTYA)
- Chronic lymphocytic leukaemia
- Hepatoblastoma (CTYA)
- Hodgkins and non-hodgkins lymphoma (ICD10 C81-88)
- Medulloblastoma
- Multiple myeloma
- Neuroblastoma
- Neuroendocrine tumours of the foregut
- Neuroendocrine tumours of the midgut and hindgut
- Non-hodgkin lymphoma (children)
- Wilms tumour of the kidney